Fairview Capital Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,000
| Closed | -$271K | – | 149 |
|
|
2024
Q1 | $271K | Hold |
5,000
| – | – | 0.02% | 138 |
|
|
2023
Q4 | $257K | Hold |
5,000
| – | – | 0.02% | 135 |
|
|
2023
Q3 | $290K | Hold |
5,000
| – | – | 0.02% | 127 |
|
|
2023
Q2 | $320K | Hold |
5,000
| – | – | 0.02% | 122 |
|
|
2023
Q1 | $347K | Sell |
5,000
-90
| -2% | -$6.24K | 0.02% | 120 |
|
|
2022
Q4 | $366K | Sell |
5,090
-100
| -2% | -$7.2K | 0.03% | 116 |
|
|
2022
Q3 | $368K | Buy |
5,190
+100
| +2% | +$7.09K | 0.03% | 105 |
|
|
2022
Q2 | $391K | Buy |
+5,090
| New | +$391K | 0.03% | 105 |
|